Details werden geladen...
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
WALTHAM, Mass., July 24, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that it has granted inducement equity awards to 12 newly hired employees. The awards were made as an inducement material to the newly hired employees’ acceptance of employment with Dyne in accordance with Nasdaq Listing Rule 5635(c)(4).
Ähnliche Seiten
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/06/03/tmt-newswire/globenewswire/dianthus-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4/2357294Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/06/03/tmt-newswire/globenewswire/monte-rosa-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2357297Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/06/03/tmt-newswire/globenewswire/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2357662Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/06/06/tmt-newswire/globenewswire/intellia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2359852
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/07/16/tmt-newswire/globenewswire/eyepoint-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2385775